Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
PaperCitations, authors & open-access status
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 657 citations, 2021 year and closed oa status.
657
Citations
2021
Year
closed
OA Status